ELIVAX
DEAD

Serial Number

97151094

Owner

Elixirgen Therapeutics, Inc.

Attorney

Leonard D. Bowersox

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ELIVAX Trademark

Serial Number: 97151094

ELIVAX is a trademark filed by Elixirgen Therapeutics, Inc. on December 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Elixirgen Therapeutics, Inc. (38 trademarks)

855 N. Wolfe St., Suite 624
Baltimore, MD 21205

Entity Type: 03

Trademark Details

Filing Date

December 1, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Vaccines for human use; vaccines for animals; pharmaceutical drugs for the treatment of cancer; vaccines for the treatment of cancer; vaccine adjuvants

Medical services, namely, inoculating people with vaccines; administering vaccines

Research and development of vaccines and medicines

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 24, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 24, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 20, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 20, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 20, 2022 CNEA
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP